+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

APAC Active Pharmaceutical Ingredients Market 2021-2028

  • PDF Icon

    Report

  • 192 Pages
  • February 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5118614
Asia Pacific active pharmaceutical ingredients market will grow by 8.8% annually with a total addressable market cap of $691.3 billion over 2021-2028, driven by rising adoption of biologics in disease management, increasing regulatory approvals, patent expiration of major drugs, growing trend of outsourcing and increase in geriatric population.



Highlighted with 92 tables and 68 figures, this 192-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2021-2028 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific active pharmaceutical ingredients market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2028 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Five Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific active pharmaceutical ingredients market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.


Synthetic API

  • Branded Synthetic API
  • Generic Synthetic API

Biotech API by Drug Type:

  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
  • Other Biotech APIs

Biotech API by Customer Base:

  • Innovative Biologic API
  • Generic Biosimilar API

Biotech API by Expression Technology:

  • Mammalian Expression
  • Microbial Expression
  • Yeast Expression
  • Insect Expression
  • Other Expression Technologies

HPAPI

  • Branded HPAPI
  • Generic HPAPI

Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.


Captive Manufacturing

  • Branded Captive API
  • Generic Captive API

Merchant Manufacturing by Drug Type:

  • Branded Merchant API
  • Generic Merchant API

Merchant Manufacturing by Drug Synthesis:

  • Merchant Synthetic API
  • Merchant Biotech API

By Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Infectious Diseases
  • Oncology
  • Ophthalmology
  • Cardiovascular Disorders
  • Central Nervous System
  • Pulmonary Disorders
  • Orthopedics
  • Other Applications

By Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ bn) for 2018-2028 included in each section.

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Drugs

Geographically, the following national/local markets are fully investigated:UK

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and data for annual revenue ($ bn) are available for 2018-2028. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the APAC Active Pharmaceutical Ingredients (API) Market

What is the estimated value of the APAC Active Pharmaceutical Ingredients (API) Market?

The APAC Active Pharmaceutical Ingredients (API) Market was estimated to be valued at $69010 Million in 2021.

What is the growth rate of the APAC Active Pharmaceutical Ingredients (API) Market?

The growth rate of the APAC Active Pharmaceutical Ingredients (API) Market is 8.8%, with an estimated value of $124160 Million by 2028.

What is the forecasted size of the APAC Active Pharmaceutical Ingredients (API) Market?

The APAC Active Pharmaceutical Ingredients (API) Market is estimated to be worth $124160 Million by 2028.

Who are the key companies in the APAC Active Pharmaceutical Ingredients (API) Market?

Key companies in the APAC Active Pharmaceutical Ingredients (API) Market include Selected Key Players:, AbbVie Inc., Astrazeneca, Aurobindo Pharma Ltd., BASF, Bayer AG, Boehringer Ingelheim, Catalent Inc. and F. Hoffmann.

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Five Forces Analysis
3 Segmentation of Asia Pacific Market by Synthesis
3.1 Market Overview by Synthesis
3.2 Synthetic API
3.2.1 Branded Synthetic API
3.2.2 Generic Synthetic API
3.3 Biotech API
3.3.1 Biotech API by Drug Type
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Vaccines
3.3.1.4 Other Biotech APIs
3.3.2 Biotech API by Category
3.3.2.1 Innovative Biologic API
3.3.2.2 Generic Biosimilar API
3.3.3 Biotech API by Expression Technology
3.3.3.1 Mammalian Expression
3.3.3.2 Microbial Expression
3.3.3.3 Yeast Expression
3.3.3.4 Insect Expression
3.3.3.5 Other Expression Technologies
3.4 HPAPI
3.4.1 Branded HPAPI
3.4.2 Generic HPAPI
4 Segmentation of Asia Pacific Market by Manufacturing Process
4.1 Market Overview by Manufacturing Process
4.2 Captive Manufacturing
4.2.1 Branded Captive API
4.2.2 Generic Captive API
4.3 Merchant Manufacturing
4.3.1 Merchant Manufacturing by Drug Type
4.3.1.1 Branded Merchant API
4.3.1.2 Generic Merchant API
4.3.2 Merchant Manufacturing by Drug Synthesis
4.3.2.1 Merchant Synthetic API
4.3.2.2 Merchant Biotech API
5 Segmentation of Asia Pacific Market by Therapeutic Application
5.1 Market Overview by Therapeutic Application
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Pulmonary Disorders
5.8 Orthopedics
5.9 Other Applications
6 Segmentation of Asia Pacific Market by Drug Type
6.1 Market Overview by Drug Type
6.2 Branded Prescription Drugs
6.3 Generic Prescription Drugs
6.4 OTC Drugs
7 Asia-Pacific Market 2021-2028 by Country
7.1 Overview of Asia-Pacific Market
7.2 China
7.3 Japan
7.4 India
7.5 Australia
7.6 South Korea
7.7 Rest of APAC Region
8 Competitive Landscape
8.1 Overview of Key Vendors
8.2 New Product Launch, Partnership, Investment, and M&A
8.3 Company Profiles
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

9 Investing in Asia Pacific Market: Risk Assessment and Management
9.1 Risk Evaluation of Asia Pacific Market
9.2 Critical Success Factors (CSFs)

List of Tables:

Table 1. Snapshot of Asia Pacific Active Pharmaceutical Ingredients (API) Market in Balanced Perspective, 2021-2028
Table 2. World Economic Outlook, 2021-2031
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. Main Product Trends and Market Opportunities in Asia Pacific Active Pharmaceutical Ingredients (API) Market
Table 5. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 6. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API by Drug Type, 2018-2028, $ bn
Table 7. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Drug Type, 2018-2028, $ bn
Table 8. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Category, 2018-2028, $ bn
Table 9. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API by Expression Technology, 2018-2028, $ bn
Table 10. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI by Drug Type, 2018-2028, $ bn
Table 11. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 12. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing by Drug Type, 2018-2028, $ bn
Table 13. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Type, 2018-2028, $ bn
Table 14. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing by Drug Synthesis, 2018-2028, $ bn
Table 15. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, $ bn
Table 17. APAC Active Pharmaceutical Ingredients (API) Market by Country, 2018-2028, $ bn
Table 18. China Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 19. China Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 20. China Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 21. Japan Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 22. Japan Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 23. Japan Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 24. India Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 25. India Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 26. India Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 27. Australia Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 28. Australia Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 29. Australia Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 30. South Korea Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, $ bn
Table 31. South Korea Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, $ bn
Table 32. South Korea Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, $ bn
Table 33. Active Pharmaceutical Ingredients (API) Market in Rest of APAC by Country, 2018-2028, $ bn
Table 34. AbbVie Inc.: Company Snapshot
Table 35. AbbVie Inc.: Product Portfolio
Table 36. AbbVie Inc.: Revenue, 2018-2020, $ bn
Table 37. Astrazeneca: Company Snapshot
Table 38. Astrazeneca: Revenue, 2018-2020, $ bn
Table 39. Aurobindo Pharma Ltd.: Company Snapshot
Table 40. Aurobindo Pharma Ltd.: Product Portfolio
Table 41. BASF: Company Snapshot
Table 42. BASF: Business Segmentation
Table 43. BASF: Revenue by Region
Table 44. Bayer AG: Company Snapshot
Table 45. Bayer AG: Business Segmentation
Table 46. Bayer AG: Revenue, 2018-2020, € bn
Table 47. Boehringer Ingelheim: Company Snapshot
Table 48. Boehringer Ingelheim: Business Segmentation in 2019
Table 49. Boehringer Ingelheim: Product Portfolio
Table 50. Boehringer Ingelheim: Revenue, 2018-2020, EUR billion
Table 51. Boehringer Ingelheim: Revenue by Region in 2019
Table 52. Catalent Inc.: Company Snapshot
Table 53. Catalent Inc.: Business Segmentation in 2018
Table 54. Catalent Inc.: Product Portfolio
Table 55. Catalent Inc.: Revenue, 2018-2020, $ million
Table 56. Catalent Inc.: Revenue by Region in 2018
Table 57. Dr. Reddy's Laboratories: Company Snapshot
Table 58. Dr. Reddy's Laboratories: Business Segmentation
Table 59. Dr. Reddy's Laboratories: Revenue, 2019-2021, $ bn
Table 60. F. Hoffmann-La Roche: Company Snapshot
Table 61. F. Hoffmann-La Roche: Business Segmentation
Table 62. GlaxoSmithKline: Company Snapshot
Table 63. GlaxoSmithKline: Business Segmentation
Table 64. GlaxoSmithKline: Product Portfolio
Table 65. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 66. Lonza Group: Company Snapshot
Table 67. Lonza Group: Business Segmentation in 2018
Table 68. Lonza Group: Product Portfolio
Table 69. Lonza Group: Revenue by Region in 2018
Table 70. Lupin Limited: Company Snapshot
Table 71. Lupin Limited: Business Segmentation
Table 72. Merck & Co., Inc.: Company Snapshot
Table 73. Merck & Co., Inc.: Business Segmentation
Table 74. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 75. Mylan NV: Company Snapshot
Table 76. Mylan NV: Revenue, 2017-2019, $ bn
Table 77. Novartis International AG: Company Snapshot
Table 78. Novartis International AG: Business Segmentation
Table 79. Novartis International AG: Revenue, 2017-2019, $ bn
Table 80. Pfizer Inc.: Company Snapshot
Table 81. Pfizer Inc.: Business Segmentation
Table 82. Pfizer Inc.: Product Portfolio
Table 83. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 84. Sanofi: Company Snapshot
Table 85. Sanofi: Business Segmentation
Table 86. Sanofi: Revenue, 2018-2020, $ bn
Table 87. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 88. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 89. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 90. Thermo Fisher Scientific: Company Snapshot
Table 91. Risk Evaluation for Investing in Asia Pacific Market, 2021-2028
Table 92. Critical Success Factors and Key Takeaways

List of Figures:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2028
Figure 4. Asia Pacific Active Pharmaceutical Ingredients (API) Market, 2021-2028, $ bn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 7. GDP per capita in the World, 1960-2018, $ thousand
Figure 8. Leading Causes of Death in the World, 2019-2020, million
Figure 9. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 10. World Population 65 and Over, % of Total Population, 1950-2060
Figure 11. Primary Restraints and Impact Factors of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 12. Investment Opportunity Analysis
Figure 13. Porter’s Five Forces Analysis of Asia Pacific Active Pharmaceutical Ingredients (API) Market
Figure 14. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Synthesis, 2018-2028, % of Revenue
Figure 15. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Synthesis, Value ($ bn) and Share (%)
Figure 16. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Synthetic API, 2018-2028, $ bn
Figure 17. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Synthetic API, 2018-2028, $ bn
Figure 18. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Synthetic API, 2018-2028, $ bn
Figure 19. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Biotech API, 2018-2028, $ bn
Figure 20. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Monoclonal Antibodies, 2018-2028, $ bn
Figure 21. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Recombinant Proteins, 2018-2028, $ bn
Figure 22. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Vaccines, 2018-2028, $ bn
Figure 23. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Biotech APIs, 2018-2028, $ bn
Figure 24. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Innovative Biologic API, 2018-2028, $ bn
Figure 25. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Biosimilar API, 2018-2028, $ bn
Figure 26. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Mammalian Expression, 2018-2028, $ bn
Figure 27. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Microbial Expression, 2018-2028, $ bn
Figure 28. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Yeast Expression, 2018-2028, $ bn
Figure 29. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Insect Expression, 2018-2028, $ bn
Figure 30. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Expression Technologies, 2018-2028, $ bn
Figure 31. Asia Pacific Active Pharmaceutical Ingredients (API) Market: HPAPI, 2018-2028, $ bn
Figure 32. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded HPAPI, 2018-2028, $ bn
Figure 33. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic HPAPI, 2018-2028, $ bn
Figure 34. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Manufacturing Process, 2018-2028, % of Revenue
Figure 35. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Manufacturing Process, Value ($ bn) and Share (%)
Figure 36. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Captive Manufacturing, 2018-2028, $ bn
Figure 37. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Captive API, 2018-2028, $ bn
Figure 38. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Captive API, 2018-2028, $ bn
Figure 39. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Manufacturing, 2018-2028, $ bn
Figure 40. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Merchant API, 2018-2028, $ bn
Figure 41. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Merchant API, 2018-2028, $ bn
Figure 42. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Synthetic API, 2018-2028, $ bn
Figure 43. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Merchant Biotech API, 2018-2028, $ bn
Figure 44. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Therapeutic Application, 2018-2028, % of Revenue
Figure 45. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Therapeutic Application, Value ($ bn) and Share (%)
Figure 46. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Infectious Diseases, 2018-2028, $ bn
Figure 47. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Oncology, 2018-2028, $ bn
Figure 48. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Ophthalmology , 2018-2028, $ bn
Figure 49. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Cardiovascular Disorders, 2018-2028, $ bn
Figure 50. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Central Nervous System, 2018-2028, $ bn
Figure 51. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Pulmonary Disorders, 2018-2028, $ bn
Figure 52. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Orthopedics, 2018-2028, $ bn
Figure 53. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Other Applications, 2018-2028, $ bn
Figure 54. Breakdown of Asia Pacific Active Pharmaceutical Ingredients (API) Market by Drug Type, 2018-2028, % of Revenue
Figure 55. Contribution to Asia Pacific 2022-2028 Cumulative Revenue by Drug Type, Value ($ bn) and Share (%)
Figure 56. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Branded Prescription Drugs, 2018-2028, $ bn
Figure 57. Asia Pacific Active Pharmaceutical Ingredients (API) Market: Generic Prescription Drugs, 2018-2028, $ bn
Figure 58. Asia Pacific Active Pharmaceutical Ingredients (API) Market: OTC Drugs, 2018-2028, $ bn
Figure 59. Breakdown of APAC Active Pharmaceutical Ingredients (API) Market by Country, 2021 and 2028, % of Revenue
Figure 60. Contribution to APAC 2022-2028 Cumulative Revenue by Country, Value ($ bn) and Share (%)
Figure 61. Active Pharmaceutical Ingredients (API) Market in China, 2018-2028, $ bn
Figure 62. Active Pharmaceutical Ingredients (API) Market in Japan, 2018-2028, $ bn
Figure 63. Active Pharmaceutical Ingredients (API) Market in India, 2018-2028, $ bn
Figure 64. Active Pharmaceutical Ingredients (API) Market in Australia, 2018-2028, $ bn
Figure 65. Active Pharmaceutical Ingredients (API) Market in South Korea, 2018-2028, $ bn
Figure 66. Active Pharmaceutical Ingredients (API) Market in Rest of APAC, 2018-2028, $ bn
Figure 67. Growth Stage of Asia Pacific Active Pharmaceutical Ingredients (API) Industry over the Forecast Period
Figure 68. Top products of AstraZeneca based on revenue from 2016 to 2019 (in million U.S. dollars)

Companies Mentioned

  • Selected Key Players:
  • AbbVie Inc.
  • Astrazeneca
  • Aurobindo Pharma Ltd.
  • BASF
  • Bayer AG
  • Boehringer Ingelheim
  • Catalent Inc.
  • Dr. Reddy's Laboratories
  • F. Hoffmann-La Roche
  • GlaxoSmithKline plc
  • Lonza Group
  • Lupin Limited
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...